173 related articles for article (PubMed ID: 23767999)
1. High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients.
Magnussen GI; Hellesylt E; Nesland JM; Trope CG; Flørenes VA; Holm R
BMC Cancer; 2013 Jun; 13():288. PubMed ID: 23767999
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro.
Wang Z; Førsund MS; Trope CG; Nesland JM; Holm R; Slipicevic A
Cancer Med; 2018 Aug; 7(8):3955-3964. PubMed ID: 29963769
[TBL] [Abstract][Full Text] [Related]
3. High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy.
Magnussen GI; Holm R; Emilsen E; Rosnes AK; Slipicevic A; Flørenes VA
PLoS One; 2012; 7(6):e38254. PubMed ID: 22719872
[TBL] [Abstract][Full Text] [Related]
4. The role of cofilin-l in vulvar squamous cell carcinoma: A marker of carcinogenesis, progression and targeted therapy.
Wu Q; Jiang Y; Cui S; Wang Y; Wu X
Oncol Rep; 2016 May; 35(5):2743-54. PubMed ID: 26936386
[TBL] [Abstract][Full Text] [Related]
5. Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions.
Slipicevic A; Holth A; Hellesylt E; Tropé CG; Davidson B; Flørenes VA
Gynecol Oncol; 2014 Oct; 135(1):118-24. PubMed ID: 25093290
[TBL] [Abstract][Full Text] [Related]
6. Expression of p15INK⁴b and p57KIP² and relationship with clinicopathological features and prognosis in patients with vulvar squamous cell carcinoma.
Holm R; Førsund M; Nguyen MT; Nesland JM; Trope CG
PLoS One; 2013; 8(4):e61273. PubMed ID: 23580324
[TBL] [Abstract][Full Text] [Related]
7. Expression of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (total) and pCyclin B1(Ser126) in vulvar squamous cell carcinoma and their relations with clinicopatological features and prognosis.
Wang Z; Slipicevic A; Førsund M; Trope CG; Nesland JM; Holm R
PLoS One; 2015; 10(4):e0121398. PubMed ID: 25849598
[TBL] [Abstract][Full Text] [Related]
8. Tumour suppressive effects of WEE1 gene silencing in neuroblastomas.
Tashnizi AH; Jaberipour M; Razmkhah M; Rahnama S; Habibagahi M
J Cancer Res Ther; 2016; 12(1):221-7. PubMed ID: 27072241
[TBL] [Abstract][Full Text] [Related]
9. p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas.
Knopp S; Bjørge T; Nesland JM; Tropé C; Scheistrøen M; Holm R
Gynecol Oncol; 2004 Oct; 95(1):37-45. PubMed ID: 15385108
[TBL] [Abstract][Full Text] [Related]
10. immunohistochemical expression of survivin and γ-H2AX in vulvar intraepithelial neoplasia and low-stage squamous cell carcinoma.
Brustmann H; Hinterholzer S; Brunner A
Int J Gynecol Pathol; 2011 Nov; 30(6):583-90. PubMed ID: 21979596
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes.
Wang Z; Trope CG; Flørenes VA; Suo Z; Nesland JM; Holm R
BMC Cancer; 2010 May; 10():233. PubMed ID: 20500813
[TBL] [Abstract][Full Text] [Related]
12. Expression of cell-cycle-associated proteins pRB2/p130 and p27kip in vulvar squamous cell carcinomas.
Zamparelli A; Masciullo V; Bovicelli A; Santini D; Ferrandina G; Minimo C; Terzano P; Costa S; Cinti C; Ceccarelli C; Mancuso S; Scambia G; Bovicelli L; Giordano A
Hum Pathol; 2001 Jan; 32(1):4-9. PubMed ID: 11172288
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus.
Rolfe KJ; Eva LJ; MacLean AB; Crow JC; Perrett CW; Reid WM
Int J Gynecol Cancer; 2001; 11(2):113-8. PubMed ID: 11328409
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas.
Wang Z; Tropè CG; Suo Z; Trøen G; Yang G; Nesland JM; Holm R
BMC Cancer; 2008 Oct; 8():308. PubMed ID: 18950492
[TBL] [Abstract][Full Text] [Related]
15. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells.
Ghiasi N; Habibagahi M; Rosli R; Ghaderi A; Yusoff K; Hosseini A; Abdullah S; Jaberipour M
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6605-11. PubMed ID: 24377575
[TBL] [Abstract][Full Text] [Related]
16. The role of RhoA in vulvar squamous cell carcinoma: a carcinogenesis, progression, and target therapy marker.
Wang J; Wu Q; Zhang LH; Zhao YX; Wu X
Tumour Biol; 2016 Mar; 37(3):2879-90. PubMed ID: 26409448
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of 14-3-3 isoforms in vulvar squamous cell carcinoma cases: 14-3-3β and ε are independent prognostic factors for these tumors.
Wang Z; Nesland JM; Suo Z; Trope CG; Holm R
PLoS One; 2011; 6(9):e24843. PubMed ID: 21935479
[TBL] [Abstract][Full Text] [Related]
18. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva.
van der Avoort IA; van de Nieuwenhof HP; Otte-Höller I; Nirmala E; Bulten J; Massuger LF; van der Laak JA; Slootweg PJ; de Hullu JA; van Kempen LC
Hum Pathol; 2010 Oct; 41(10):1475-85. PubMed ID: 20656324
[TBL] [Abstract][Full Text] [Related]
19. Concordant p53 and mdm-2 protein expression in vulvar squamous cell carcinoma and adjacent lichen sclerosus.
Carlson JA; Amin S; Malfetano J; Tien AT; Selkin B; Hou J; Goncharuk V; Wilson VL; Rohwedder A; Ambros R; Ross JS
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):150-63. PubMed ID: 11396633
[TBL] [Abstract][Full Text] [Related]
20. Expression of ZNF652, a novel zinc finger protein, in vulvar carcinomas and its relation to prognosis.
Holm R; Knopp S; Kumar R; Lee J; Nesland JM; Tropè C; Callen DF
J Clin Pathol; 2008 Jan; 61(1):59-63. PubMed ID: 17468294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]